A Review of Animal Study Evidence for Stem Cell and Exosome Therapies to Improve Health and Extend Life
Key claim: Current stem cell and exosome therapies reliably suppress systemic inflammation for several months, but producing meaningful or consistent functional tissue regeneration remains largely hit-or-miss.
Abstract
A sizable number of humans have received first generation stem cell therapies, with considerable variation in protocols and sources of cells. Only a small fraction of these patients and treatments resulted in data that was robustly recorded and made available to the rest of the world, as only a small fraction of those patients were participants in clinical trials. Stem cell therapies (and, given more time, likely exosome therapies as well) have an entirely justified reputation as being unreliable in outcome. The available evidence suggests a fairly reliable reduction in chronic inflammation for a period of months, but whether or not a patient exhibits improved function in tissues, and to what degree, is a roll of the dice. One of the reasons why the world […]
Why this matters
Current stem cell and exosome therapies reliably suppress systemic inflammation for several months, but producing meaningful or consistent functional tissue regeneration remains largely hit-or-miss.